- Gilead lifted by $3.6B 1Q sales of newest hepatitis C pill Updated: Apr-30-15 5:20 pm
FOSTER CITY, California - Gilead Sciences raked in $3.6 billion from sales of its newest hepatitis C pill, lifting the drugmaker's results past Wall Street expectations.
- New meds help drugmakers weather strong dollar, other issues Updated: Apr-28-15 4:50 pm
Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their revenue from selling products overseas. Because they're purchased in local currencies, the strong dollar is depressing the sales' value.
- AbbVie raises outlook as Humira again delivers earnings beat Updated: Apr-23-15 10:49 am
WASHINGTON - Drugmaker AbbVie is raising its full-year earnings guidance after reporting better-than-expected first quarter adjusted results on continued growth of its blockbuster anti-inflammatory drug Humira.
- Former Atlanta TV anchor diagnosed with liver cancer Updated: Apr-23-15 4:34 am
ATLANTA - Longtime Atlanta news anchor Monica Pearson has revealed she's been diagnosed with liver cancer.
- New drugs effective at treating hepatitis C, but at a price Updated: Apr-20-15 3:34 am
PROVIDENCE, Rhode Island - Rhode Island Department of Corrections officials say that new drugs are effective at treating hepatitis C. But their steep price has made it difficult to decide when to treat inmates and how to pay for their care.
- Specialty, generic drug costs drive Medicaid costs up Updated: Apr-11-15 12:38 pm
JEFFERSON CITY, Missouri - The high cost of a drug used to treat Medicaid patients with hepatitis C drew scrutiny from lawmakers earlier this year, but other drugs are also driving up the state's costs and likely will continue to do so for several years, government data reveals.
- Merck's potential HCV drug gets special FDA designation Updated: Apr-08-15 7:29 am
NEW YORK - Merck & Co. said Wednesday that the Food and Drug Administration granted the pharmaceutical company's developing hepatitis C treatment two special designations.
- Health officials probe possible virus exposure at clinic Updated: Apr-07-15 1:58 pm
SANTA BARBARA, California - Health officials are investigating whether patients who got shots at a medical clinic in Santa Barbara County may have been exposed to hepatitis or other blood-borne illnesses.